Timing of stroke in patients undergoing total hip replacement and matched controls: A nationwide cohort study

Stroke

Volumn 43, Issue 12, 2012, Pages 3225-3229

  Lalmohamed, Arief ^a,b   Vestergaard, Peter ^c   Cooper, Cyrus ^d,e   De Boer, Anthonius ^a   Leufkens, Hubertus G M ^a   Van Staa, Tjeerd P ^a,d   De Vries, Frank ^a,d,f,g  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c AALBORG UNIVERSITY   (Denmark)

^d SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Arthroplasty; Hip replacement; Intracranial hemorrhages; Osteoarthritis; Pharmacoepidemiology; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CIRAMADOL; CORTICOSTEROID; ENOXAPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOOP DIURETIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; ORGANIC NITRATE; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG USE; FEMALE; HAZARD RATIO; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTPATIENT CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; TOTAL HIP PROSTHESIS;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; COHORT STUDIES; COMORBIDITY; DENMARK; DIURETICS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROPORTIONAL HAZARDS MODELS; PSYCHOTROPIC DRUGS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TIME FACTORS;

EID: 84870886079     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.668509     Document Type: Article

References (37)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371:1612-1623.
2. th century. Lancet Neurol. 2003;2:43-53.
3. Bateman BT, Schumacher HC, Wang S, Shaef S, Berman MF. Perioperative acute ischemic stroke in noncardiac and nonvascular surgery: incidence, risk factors, and outcomes. Anesthesiology. 2009;110:231-238.
4. Harris WH, Sledge CB. Total hip and total knee replacement (1). N Engl J Med. 1990;323:725-731.
5. Lanes S, Fraeman K, Meyers A, Wood Ives J, Huang HY. Incidence rates for thromboembolic, bleeding and hepatic outcomes in patients undergoing hip or knee replacement surgery. J Thromb Haemost. 2011;9:325-332.
6. Mortazavi SM, Kakli H, Bican O, Moussouttas M, Parvizi J, Rothman RH. Perioperative stroke after total joint arthroplasty: prevalence, predictors, and outcome. J Bone Joint Surg Am. 2010;92:2095-2101.
7. Popa AS, Rabinstein AA, Huddleston PM, Larson DR, Gullerud RE, Huddleston JM. Predictors of ischemic stroke after hip operation: a population-based study. J Hosp Med. 2009;4:298-303.
8. Parvizi J, Mui A, Purtill JJ, Sharkey PF, Hozack WJ, Rothman RH. Total joint arthroplasty: When do fatal or near-fatal complications occur? J Bone Joint Surg Am. 2007;89:27-32.
9. Datamonitor Healthcare. Report: Hip and knee replacement market. Product code: DMHC2264. London.
10. Research AFH, Quality. Healthcare Cost and Utilization Project 2009. Rockvile, MD: Agency for Healthcare Research and Quality; 2009.
11. den Hertog HM, van der Worp HB, van Gemert HM, van Gijn J, Koudstaal PJ, Dippel DW. Effects of high-dose paracetamol on blood pressure in acute stroke. Acta Neurol Scand. 2012;125:265-271.
12. Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Jüni P. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ. 2011;342:c7086.
13. de Vries F, Setakis E, van Staa TP. Concomitant use of ibuprofen and paracetamol and the risk of major clinical safety outcomes. Br J Clin Pharmacol. 2010;70:429-438.
14. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P. Stroke. Lancet. 2003;362:1211-1224.
15. Bak S, Tsiropoulos I, Kjaersgaard JO, Andersen M, Mellerup E, Hallas J, García Rodríguez LA, Christensen K, Gaist D. Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke. 2002;33:1465-1473.
16. Douglas IJ, Smeeth L. Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ. 2008;337:a1227.
17. Klungel OH, Heckbert SR, Longstreth WT Jr, Furberg CD, Kaplan RC, Smith NL, Lemaitre RN, Leufkens HG, de Boer A, Psaty BM. Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med. 2001;161:37-43.
18. Mary V, Wahl F, Uzan A, Stutzmann JM. Enoxaparin in experimental stroke: neuroprotection and therapeutic window of opportunity. Stroke. 2001;32:993-999.
19. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
20. Krarup LH, Boysen G, Janjua H, Prescott E, Truelsen T. Validity of stroke diagnoses in a National Register of Patients. Neuroepidemiology. 2007;28:150-154.
21. Greenland S. Modeling and variable selection in epidemiologic analysis. Am J Public Health. 1989;79:340-349.
22. Lalmohamed A, Opdam F, Arden NK, Prieto-Alhambra D, van Staa T, Leufkens HG, de Vries F. Knee arthroplasty and risk of hip fracture: a population-based, case-control study. Calcif Tissue Int. 2012;90:144-150.
23. Pouwels S, Lalmohamed A, Leufkens B, de Boer A, Cooper C, van Staa T, de Vries F. Risk of hip/femur fracture after stroke: a population-based case-control study. Stroke. 2009;40:3281-3285.
24. Lalmohamed A, de Vries F, Bazelier MT, Cooper A, van Staa TP, Cooper C, Harvey NC. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ. 2012;345:e5085.
25. Lalmohamed A, Vestergaard P, Klop C, Grove EL, de Boer A, Leufkens HG, van Staa TP, de Vries F. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study. Arch Intern Med. 2012;172:1229-1235.
26. Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol. 1998;55:1475-1482.
27. Jones RH. Physiologic emboli changes observed during total hip replacement arthroplasty. A clinical prospective study. Clin Orthop Relat Res. 1975;112:192-200.
28. Caillouette JT, Anzel SH. Fat embolism syndrome following the intramedullary alignment guide in total knee arthroplasty. Clin Orthop Relat Res. 1990;251:198-199.
29. Forteza AM, Koch S, Campo-Bustillo I, Gutierrez J, Haussen DC, Rabinstein AA, Romano J, Zych GA, Duncan R. Transcranial Doppler detection of cerebral fat emboli and relation to paradoxical embolism: a pilot study. Circulation. 2011;123:1947-1952.
30. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, Wassertheil-Smoller S, Turan TN, Wentworth D; American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/american stroke association. Stroke. 2011;42:227-276.
31. Johnson ES, Lanes SF, Wentworth CE III, Satterfield MH, Abebe BL, Dicker LW. A metaregression analysis of the dose-response effect of aspirin on stroke. Arch Intern Med. 1999;159:1248-1253.
32. Hu G, Tuomilehto J, Silventoinen K, Sarti C, Männistö S, Jousilahti P. Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med. 2007;167:1420-1427.
33. Song YM, Sung J, Davey Smith G, Ebrahim S. Body mass index and ischemic and hemorrhagic stroke: a prospective study in Korean men. Stroke. 2004;35:831-836.
34. Oliveria SA, Felson DT, Cirillo PA, Reed JI, Walker AM. Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology. 1999;10:161-166.
35. Reijman M, Pols HA, Bergink AP, Hazes JM, Belo JN, Lievense AM, Bierma-Zeinstra SM. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis. 2007;66:158-162.
36. Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010;92:2156-2164.
37. Bath PM, Iddenden R, Bath FJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke. 2000;31:1770-1778.